期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Anti-obesity effects of fucoidan from Sargassum thunbergii in adipocytes and high fat diet induced obese mice through inhibiting adipogenic specific transcription factor
1
作者 hyo-Geun Lee h.h.A.c.k.jayawardhana +7 位作者 Fengqi Yang D.P.Nagahawaththa N.M.Liyanage kyung-Mo Song Yun-Sang choi Seung-hong Lee You-Jin Jeon Min-cheol kang 《Food Science and Human Wellness》 SCIE CSCD 2024年第3期1608-1616,共9页
The prevalence of obesity has increased and is a health concern worldwide.Due to the concerns regarding synthetic anti-obesity treatments,nowadays natural products become a trend.Previous studies proved that there is ... The prevalence of obesity has increased and is a health concern worldwide.Due to the concerns regarding synthetic anti-obesity treatments,nowadays natural products become a trend.Previous studies proved that there is a potential to use marine algae as anti-obesity agents.Therefore,in this study,the lipid inhibitory effect of crude polysaccharide of amyloglucosidase-assisted hydrolysate from Sargassum thunbergii(STAC)and its fucoidan fractions(STAFs)on 3T3-L1 cells and high-fat diet(HFD)-induced obese mice were investigated.According to the results,the STAF3,showed the highest xylose content and exhibited significant inhibitory effects on lipid accumulation by downregulating adipogenic and lipogenic proteins in 3T3-L1 cells.Furthermore,oral supplementation with STAC significantly declined gain in body weight and fat weight,and serum lipid contents in an HFD-induced obesity mouse model.Structural and chemical characterizations demonstrated that puritied STAF3 has consistent surface morphology and small particle size,with similar structural characteristics as commercial fucoidan.Together,these results indicate that STAC and purified STAF3 from Sargassum thunbergia is a potent source to develop as ananti-obesity agents or functional food products to counter obesity. 展开更多
关键词 Sargassum thunbergii FUCOIDAN ANTI-OBESITY Anti-steatosis
下载PDF
Role of marine natural products in the development of antiviral agents against SARS‑CoV‑2:potential and prospects
2
作者 D.P.Nagahawatta N.M.Liyanage +4 位作者 Thilina U.Jayawardena h.h.A.c.k.jayawardhana Seong‑hun Jeong hyung‑Jun kwon You‑Jin Jeon 《Marine Life Science & Technology》 SCIE CSCD 2024年第2期280-297,共18页
A novel coronavirus,known as severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),has surfaced and caused global concern owing to its ferocity.SARS-CoV-2 is the causative agent of coronavirus disease 2019;howev... A novel coronavirus,known as severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),has surfaced and caused global concern owing to its ferocity.SARS-CoV-2 is the causative agent of coronavirus disease 2019;however,it was only discovered at the end of the year and was considered a pandemic by the World Health Organization.Therefore,the develop-ment of novel potent inhibitors against SARS-CoV-2 and future outbreaks is urgently required.Numerous naturally occurring bioactive substances have been studied in the clinical setting for diverse disorders.The intricate infection and replication mechanism of SARS-CoV-2 offers diverse therapeutic drug targets for developing antiviral medicines by employing natural products that are safer than synthetic compounds.Marine natural products(MNPs)have received increased attention in the development of novel drugs owing to their high diversity and availability.Therefore,this review article investigates the infection and replication mechanisms,including the function of the SARS-CoV-2 genome and structure.Furthermore,we highlighted anti-SARS-CoV-2 therapeutic intervention efforts utilizing MNPs and predicted SARS-CoV-2 inhibitor design. 展开更多
关键词 SARS-CoV-2 Marine natural products Drug targets INHIBITORS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部